Compare CTKB & ASIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTKB | ASIX |
|---|---|---|
| Founded | 1990 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 541.1M | 460.1M |
| IPO Year | 2021 | 2016 |
| Metric | CTKB | ASIX |
|---|---|---|
| Price | $4.62 | $16.37 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $5.63 | ★ $26.00 |
| AVG Volume (30 Days) | ★ 811.8K | 274.3K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 2.62% |
| EPS Growth | N/A | ★ 11.11 |
| EPS | ★ N/A | N/A |
| Revenue | $193,015,000.00 | ★ $1,684,625,000.00 |
| Revenue This Year | $5.42 | $4.19 |
| Revenue Next Year | $7.03 | $4.60 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 17.67 | ★ 45.49 |
| 52 Week Low | $3.28 | $14.10 |
| 52 Week High | $6.18 | $26.73 |
| Indicator | CTKB | ASIX |
|---|---|---|
| Relative Strength Index (RSI) | 52.95 | 36.17 |
| Support Level | $4.56 | $16.02 |
| Resistance Level | $4.73 | $17.29 |
| Average True Range (ATR) | 0.24 | 0.64 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 61.29 | 35.56 |
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.
AdvanSix Inc is a diversified chemistry company playing a critical role in international supply chains, innovating and delivering essential products for customers across a wide variety of end markets and applications that touch people's lives, including building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, and electronics. The company's key products include Nylon, Caprolactam, Plant Nutrients, and Chemical Intermediates. The majority of sales are from Plant Nutrients products. The company operates in the United States and internationally, with the majority of revenue coming from the United States.